Rankings
▼
Calendar
RVMD FY 2025 Earnings — Revolution Medicines, Inc. Revenue & Financial Results | Market Cap Arena
RVMD
Revolution Medicines, Inc.
$20B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$17M
Operating Income
-$1.2B
Net Income
-$1.1B
EPS (Diluted)
$-5.95
Cash Flow
Operating Cash Flow
-$898M
Free Cash Flow
-$914M
Stock-Based Comp.
$118M
Balance Sheet
Total Assets
$2.4B
Total Liabilities
$723M
Stockholders' Equity
$1.6B
Cash & Equivalents
$384M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$17M
$0
—
Operating Income
-$1.2B
-$690M
-71.5%
Net Income
-$1.1B
-$600M
-88.5%
← Q4 2024
All Quarters
Q1 2025 →